Bullseye Biotechnologies, Inc

Bullseye Biotechnologies, Inc. develops organoids-in-the-loop platforms designed to enhance drug discovery. The company integrates advanced organoid technology with closed-loop automation and artificial intelligence to create high-throughput, biologically relevant models for pharmaceutical and biotechnology research. By leveraging these systems, Bullseye Biotechnologies provides specialized products, services, and collaborative partnerships aimed at accelerating the therapeutic development process for academic and industry clients. Headquartered in the San Francisco Bay Area, the company focuses on improving human health outcomes through the application of its automated, AI-driven biological screening technologies.